Abstract
Surgery is currently the best treatment option for early stages lung cancer but is considered feasible only in low-risk patients. Risk evaluation and therapeutic strategy should be made according to international guidelines. Evaluation should focus on cardiovascular risk assessment (mostly clinically) and on pulmonary function tests, with both FEV1 and DLCO. In the 2013 guidelines from the ACCP (American College of Chest Physicians), post operative predicted FEV1 and DLCO should be calculated if FEV1 or DLCO are less than 60% of the predicted value. Dynamic tests (i. e. stair climbing, shuttle walk test or CPET) should only be performed in patients with suspected coronary disease or low predicted post operative values. Nevertheless, these guidelines do not consider prehabilitation programs and minimally invasive surgeries and should be reconsidered to allow surgery for a maximum of patients.1877-1203/© 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
